Medicare Enrolled
Dr. Robert Macgregor, M.D.
Neurology · Savannah, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Macgregor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Macgregor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Macgregor
Dr. Robert Macgregor is a neurology specialist in Savannah, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Macgregor performed 39,965 Medicare services across 1,672 unique beneficiaries.
Between the years covered by Open Payments, Dr. Macgregor received a total of $47,438 from 93 pharmaceutical and/or device companies across 1705 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Macgregor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in GA
$47,438 industry payments
Medicare Practice Summary
Medicare Utilization ↗39,965
Medicare services
Top 1% in GA for neurology
1,672
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,103 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
18,295 | $4 | $10 |
| Injection, eptinezumab-jjmr, 1 mg | 17,700 | $13 | $52 |
| MRI contrast dye injection (gadobutrol) | 1,750 | $0 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
527 | $82 | $475 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
395 | $57 | $250 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
144 | $45 | $123 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
127 | $39 | $167 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
103 | $45 | $210 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
89 | $0 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $121 | $482 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
67 | $11 | $68 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
65 | $89 | $441 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
62 | $63 | $350 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
59 | $123 | $572 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
54 | $86 | $1,250 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
50 | $34 | $100 |
| New patient office visit, complex (60-74 min) | 48 | $139 | $608 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
40 | $4 | $60 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
39 | $81 | $579 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 37 | $52 | $211 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
34 | $1 | $25 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $41 | $126 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
27 | $84 | $600 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
26 | $146 | $684 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
23 | $78 | $364 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
18 | $123 | $1,424 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
17 | $314 | $1,700 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
14 | $67 | $1,236 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
14 | $52 | $130 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
13 | $98 | $263 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $127 | $525 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
95.6% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,438
Total received (2018-2024)
Avg $6,777/year across 7 years
Top 9% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,705
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,586 (51.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,851 (48.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,183
2023
$5,025
2022
$9,589
2021
$8,146
2020
$13,461
2019
$3,181
2018
$2,854
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$479
UCB, Inc.
$476
EMD Serono, Inc.
$331
Lundbeck LLC
$322
Biogen, Inc.
$275
PFIZER INC.
$254
SK Life Science, Inc.
$220
Mallinckrodt Hospital Products Inc.
$201
Neurocrine Biosciences, Inc.
$181
Novartis Pharmaceuticals Corporation
$165
Alexion Pharmaceuticals, Inc.
$165
Neurelis, Inc.
$156
ARGENX US, INC.
$150
CATALYST PHARMACEUTICALS, INC.
$139
Genentech USA, Inc.
$138
Octapharma USA, Inc.
$119
Eisai Inc.
$116
Ipsen Biopharmaceuticals, Inc
$113
Takeda Pharmaceuticals U.S.A., Inc.
$103
JAZZ PHARMACEUTICALS INC.
$92
Amgen Inc.
$87
ACADIA Pharmaceuticals Inc
$84
Teva Pharmaceuticals USA, Inc.
$80
Sumitomo Pharma America, Inc.
$73
SCILEX PHARMACEUTICALS INC.
$67
Lilly USA, LLC
$61
CSL Behring
$56
Celgene Corporation
$55
Otsuka America Pharmaceutical, Inc.
$51
AstraZeneca Pharmaceuticals LP
$50
LivaNova USA, Inc.
$45
Grifols USA, LLC
$45
Averitas Pharma Inc.
$37
Vanda Pharmaceuticals Inc.
$34
Kyowa Kirin, Inc.
$30
Sandoz Inc.
$28
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
Merz Pharmaceuticals, LLC
$19
BANNER LIFE SCIENCES, LLC
$19
Boston Scientific Corporation
$16
Marinus Pharmaceuticals, Inc.
$16
InSightec,Inc
$14
Top 3 companies account for 24.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$23,192
EMD Serono, Inc.
$2,424
Biogen, Inc.
$1,583
ABBVIE INC.
$1,445
Teva Pharmaceuticals USA, Inc.
$1,413
UCB, Inc.
$1,366
Novartis Pharmaceuticals Corporation
$1,113
Lundbeck LLC
$956
Mallinckrodt Hospital Products Inc.
$894
SK Life Science, Inc.
$867
PFIZER INC.
$613
Amgen Inc.
$594
Allergan, Inc.
$564
Genentech USA, Inc.
$546
Ipsen Biopharmaceuticals, Inc
$507
Alexion Pharmaceuticals, Inc.
$504
Neurelis, Inc.
$503
Neurocrine Biosciences, Inc.
$456
AbbVie Inc.
$424
ARGENX US, INC.
$419
Eisai Inc.
$370
CSL Behring
$306
JAZZ PHARMACEUTICALS INC.
$267
Merz Pharmaceuticals, LLC
$258
Allergan Inc.
$251
Octapharma USA, Inc.
$234
GENZYME CORPORATION
$229
Celgene Corporation
$227
LivaNova USA, Inc.
$209
Jazz Pharmaceuticals Inc.
$190
Kyowa Kirin, Inc.
$181
Biohaven Pharmaceuticals, Inc.
$171
CATALYST PHARMACEUTICALS, INC.
$171
Mallinckrodt LLC
$168
Sunovion Pharmaceuticals Inc.
$167
Acorda Therapeutics, Inc
$164
Biohaven Pharmaceutical Holding Company Ltd.
$161
EISAI INC.
$152
Greenwich Biosciences, Inc.
$148
MITSUBISHI TANABE PHARMA AMERICA, INC.
$147
Mallinckrodt Enterprises LLC
$146
Otsuka America Pharmaceutical, Inc.
$143
ACADIA Pharmaceuticals Inc
$137
Mitsubishi Tanabe Pharma America, Inc.
$131
Takeda Pharmaceuticals U.S.A., Inc.
$126
Janssen Pharmaceuticals, Inc
$116
Avanir Pharmaceuticals, Inc.
$115
Harmony Biosciences LLC
$112
Horizon Therapeutics plc
$110
Scilex Pharmaceuticals Inc.
$104
Promius Pharma LLC
$93
Merz North America, Inc.
$82
Upsher-Smith Laboratories LLC
$79
Sumitomo Pharma America, Inc.
$73
IMPEL PHARMACEUTICALS INC.
$72
Catalyst Pharmaceuticals, Inc.
$70
Grifols USA, LLC
$69
Bausch Health US, LLC
$69
SCILEX PHARMACEUTICALS INC.
$67
AQUESTIVE THERAPEUTICS, INC.
$57
US WorldMeds, LLC
$51
TG THERAPEUTICS, INC.
$50
AstraZeneca Pharmaceuticals LP
$50
HOSPIRA, INC.
$46
HARMONY BIOSCIENCES LLC
$45
Avion Pharmaceuticals
$41
ANI Pharmaceuticals, Inc.
$41
AveXis
$37
Averitas Pharma Inc.
$37
GE HEALTHCARE
$37
Vanda Pharmaceuticals Inc.
$34
Alnylam Pharmaceuticals Inc.
$32
E.R. Squibb & Sons, L.L.C.
$31
Boston Scientific Corporation
$29
Sandoz Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$28
Sarepta Therapeutics, Inc.
$24
Supernus Pharmaceuticals, Inc.
$24
Amylyx Pharmaceuticals, Inc.
$23
Banner Life Sciences, LLC
$21
MERZ NORTH AMERICA, INC.
$20
ARBOR PHARMACEUTICALS, INC.
$20
GRT US Holding, Inc.
$20
BANNER LIFE SCIENCES, LLC
$19
AbbVie, Inc.
$18
Marinus Pharmaceuticals, Inc.
$16
Corium, LLC
$15
Akcea Therapeutics, Inc.
$15
InSightec,Inc
$14
Currax Pharmaceuticals LLC
$14
Assertio Therapeutics, Inc.
$13
Medtronic, Inc.
$12
Neos Therapeutics, LP
$12
Top 3 companies account for 57.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adzenys XR-ODT · Aimovig · Austedo XR · Azstarys · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CONTRAVE · COPAXONE · Cambia · DAYBUE · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Evrysdi · Exablate · Exondys 51 · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · Gamunex-C · General - Pain Management · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELYVRIO · REXULTI · REYVOW · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SYMPAZAN · Skyclarys · Soliris · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · WATCHMAN FLX · Wakix · XCOPRI · XEOMIN · XYREM · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOLGENSMA · ZTALMY · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for neurology in GA.
Geographic Context
Neurologists within 10 mi
26
Per 100K population
8.7
County median income
$69,575
Nearest hospital
COASTAL HARBOR TREATMENT CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Macgregor is a mixed practice specialist, with above-average Medicare volume (top 1% in GA), with low-engagement industry engagement in the top 9% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Macgregor experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Macgregor performed 18,295 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Macgregor receive payments from pharmaceutical companies?
Yes. Dr. Macgregor received a total of $47,438 from 93 companies across 1,705 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Macgregor's costs compare to other neurologists in Savannah?
Dr. Macgregor's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Macgregor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Savannah
Browse neurologists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology